Skip to main content

Table 5 Gene model validation test by discriminant analysis. Malignant or benign group allocation probability values for the unknown samples

From: The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management

Unknown samples Benign probability Malignant probability Predicted diagnosis Cytological diagnosis Pathological diagnosis BRAF status
A 0.0700 0.9300 Malignant SPTC Malignant V600E
B 0.0530 0.9470 Malignant SPTC Malignant V600E
C 0.1075 0.8925 Malignant SPTC Malignant V600E
D 0.0177 0.9823 Malignant SPTC Malignant V600E
E 0.1964 0.8036 Malignant SPTC Malignant V600E
F 0.1380 0.8620 Malignant SPTC Malignant V600E
G 0.0935 0.9065 Malignant SPTC Malignant WT
H 0.1369 0.8631 Malignant SPTC Malignant WT
I 0.1458 0.8542 Malignant SPTC Malignant V600E
L 0.2110 0.7890 Malignant SPTC Malignant WT
M 0.0415 0.9585 Malignant SPTC Malignant WT